Skip to main content
PCL. Inc logo

PCL. Inc — Investor Relations & Filings

Ticker · 241820 ISIN · KR7241820000 KO Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2022-01-24 Regulatory Filings
Country KR South Korea
Listing KO 241820

About PCL. Inc

http://www.pclchip.com/

PCL, Inc. is a company that develops and manufactures in-vitro diagnostic (IVD) medical devices, specializing in multiplex immunodiagnosis. The company's core offering is based on its proprietary SG Cap™ Technology, a platform for creating advanced diagnostic solutions. Its product portfolio includes automated multi-immune diagnostic systems, blood testing kits, cancer screening tests, and rapid antigen kits. PCL also provides platform services, reagents, and related equipment such as desktop arrayers to the medical and diagnostic fields.

Recent filings

Filing Released Lang Actions
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PCL) regarding a 'Single Sale/Supply Contract' amendment. It details a correction to a previous disclosure (dated 2021-01-25) to reveal the counterparty name (Bakter Medical) after a confidentiality period expired. Since this is a specific regulatory disclosure regarding a commercial contract and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-01-24 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PCL) regarding a 'Single Sales/Supply Contract' amendment. It details the disclosure of previously withheld information (counterparty name and region) following the expiration of a confidentiality period. This type of disclosure regarding commercial contracts and regulatory updates falls under the general regulatory filing category as it does not fit into specific categories like M&A, dividends, or financial reports.
2022-01-20 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PCL) regarding a 'Single Sales/Supply Contract' amendment. It details the correction of a previous disclosure (dated 2021-01-21) to include the counterparty name and specific supply region after a confidentiality period expired. Since this is a specific regulatory disclosure regarding a commercial contract update and does not fit into categories like M&A, dividends, or financial reports, it is classified as a general Regulatory Filing (RNS).
2022-01-20 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PCL) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It is a correction filing (정정신고) updating details of a previously disclosed contract, specifically revealing the counterparty name and supply region after a confidentiality period expired. This type of disclosure regarding specific commercial contracts and their amendments falls under general regulatory announcements.
2022-01-18 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PCL) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It is a formal disclosure of a commercial contract, specifically a correction filing (정정신고) to update details of a previously disclosed contract. Since this is a specific regulatory disclosure of a business contract and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-01-18 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PCL) regarding a 'Single Sales/Supply Contract' amendment. It details a correction to a previous disclosure (dated 2021.01.18) to reveal the counterparty name and specific supply region after a confidentiality period expired. Since this is a specific regulatory disclosure regarding a commercial contract update and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-01-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.